Drug · DIN 00654531
TRYPTAN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 11, 2021; first marketed December 31, 1986.
- Drug Identification Number (DIN)
- 00654531
- Company (DIN owner)
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Tryptophan N06AX02
- Class
- Human
- Record last updated
- January 6, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TRYPTOPHAN | 1 G |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 11, 2021: NOC 26061New Drug Submission (NDS) · Update to the product monograph. change in product ownership
- October 13, 2004: NOC 5552New Drug Submission (NDS) · Manufacturer name change
Other DINs named TRYPTAN
- DIN 00718149 · Marketed
- DIN 02029456 · Marketed
- DIN 02239326 · Marketed
- DIN 02239327 · Marketed